Gustav Marco, Reitsam Nic Gabriel, Carrero Zunamys I, Loeffler Chiara M L, van Treeck Marko, Yuan Tanwei, West Nicholas P, Quirke Philip, Brinker Titus J, Brenner Hermann, Favre Loëtitia, Märkl Bruno, Stenzinger Albrecht, Brobeil Alexander, Hoffmeister Michael, Calderaro Julien, Pujals Anaïs, Kather Jakob Nikolas
Else Kroener Fresenius Center for Digital Health, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
NPJ Precis Oncol. 2024 May 23;8(1):115. doi: 10.1038/s41698-024-00592-z.
In the spectrum of colorectal tumors, microsatellite-stable (MSS) tumors with DNA polymerase ε (POLE) mutations exhibit a hypermutated profile, holding the potential to respond to immunotherapy similarly to their microsatellite-instable (MSI) counterparts. Yet, due to their rarity and the associated testing costs, systematic screening for these mutations is not commonly pursued. Notably, the histopathological phenotype resulting from POLE mutations is theorized to resemble that of MSI. This resemblance not only could facilitate their detection by a transformer-based Deep Learning (DL) system trained on MSI pathology slides, but also indicates the possibility for MSS patients with POLE mutations to access enhanced treatment options, which might otherwise be overlooked. To harness this potential, we trained a Deep Learning classifier on a large dataset with the ground truth for microsatellite status and subsequently validated its capabilities for MSI and POLE detection across three external cohorts. Our model accurately identified MSI status in both the internal and external resection cohorts using pathology images alone. Notably, with a classification threshold of 0.5, over 75% of POLE driver mutant patients in the external resection cohorts were flagged as "positive" by a DL system trained on MSI status. In a clinical setting, deploying this DL model as a preliminary screening tool could facilitate the efficient identification of clinically relevant MSI and POLE mutations in colorectal tumors, in one go.
在结直肠肿瘤谱系中,具有DNA聚合酶ε(POLE)突变的微卫星稳定(MSS)肿瘤呈现出高突变特征,有可能像微卫星不稳定(MSI)肿瘤一样对免疫疗法产生反应。然而,由于其罕见性和相关检测成本,通常不会对这些突变进行系统筛查。值得注意的是,理论上认为POLE突变导致的组织病理学表型与MSI相似。这种相似性不仅有助于通过在MSI病理切片上训练的基于Transformer的深度学习(DL)系统对其进行检测,还表明携带POLE突变的MSS患者有可能获得更多的治疗选择,否则这些选择可能会被忽视。为了利用这一潜力,我们在一个具有微卫星状态真实数据的大型数据集上训练了一个深度学习分类器,随后在三个外部队列中验证了其检测MSI和POLE的能力。我们的模型仅使用病理图像就能准确识别内部和外部切除队列中的MSI状态。值得注意的是,在分类阈值为0.5时,外部切除队列中超过75%的POLE驱动突变患者被基于MSI状态训练的DL系统标记为“阳性”。在临床环境中,将这个DL模型作为初步筛查工具部署,可以一次性有效地识别结直肠肿瘤中与临床相关的MSI和POLE突变。